Hypoactive Sexual Desire Disorder (Hsdd) In Women
Hypoactive Sexual Desire Disorder
Hypoactive Sexual Desire Disorder At A Glance
Hypoactive sexual desire disorder (HSDD) is a type of mental and physical sexual dysfunction in which women lack motivation or desire to have sex for an extended period (at least 6 months), resulting in significant levels of personal distress - an essential component of an HSDD diagnosis.
Hypoactive sexual desire disorder affects approximately 10% of women of all ages. Low sexual desire can also affect men.
The symptoms of HSDD include reduced spontaneous sexual thoughts or fantasies, decreased sensitivity to stimulation, difficulty to sustain interest through sex, and diminished desire to initiate sex. Women suffering from HSDD may avoid situations that could lead to sexual activity.
What Is HSDD?
A medical term for various types of diminished sexual desire is hypoactive sexual desire disorder. A decrease in behavioral or physical activity is referred to as hypoactivity.
HSDD is defined as a woman's persistent and recurring loss of desire in sexual activity, sexual thoughts, and sexual stimulation, resulting in increased stress. This clinically significant stress can include feelings of sadness, grief, incompetence, loss, and frustration. The significant personal distress caused by HSDD is an important component of the diagnosis.
When a woman's symptoms cannot be attributed to another type of sexual disorder, medications, or medical and psychological conditions, hypoactive sexual desire disorder is the underlying cause.
Another aspect of an HSDD diagnosis is that this lack of interest and response lasts for at least 6 months. HSDD is a difficult condition to diagnose and treat, in part because we still don't know much about the biology of sexual desire. It is also underdiagnosed due to patients' - and even some physicians' - reluctance to discuss this very private and emotionally troubling condition.
According to the International Society for the Study of Women's Sexual Health, 10% of women have hypoactive sexual desire disorder, though the actual figure is likely much higher. A recent survey of 2,207 women revealed, 26.7% of premenopausal women and 52.4% of menopausal women have low desire and HSDD.The study estimates that at least 16 million women in their 50s and older currently experience low desire, and that 4 million of them are troubled by it.
The Causes And Risk Factors For HSDD/Low Libido In Women
Certain brain regions and functions regulate sexual desire. Dopamine and melanocortin are neurotransmitters that aid in the processing of sexual stimulation. However, sexual inhibition systems involving opioids and other substances in the brain limit sexual excitement impulses.
Although it is unclear how or why these brain inhibitory mechanisms cause hypoactive sexual desire disorder (HSDD) in women, we do know that some conditions make women more likely to have the disorder. These are some examples:
Women's HSDD/Low Libido (Sex Drive) Treatment
Treatment for hypoactive sexual desire disorder addresses the condition's psychological, social, and biological aspects. Treatment decisions are always tailored to each woman's unique situation and needs.
Addressing the suspected underlying contributing factors for HSDD is frequently the best approach, with a focus on the factors that are especially stressful to the woman. Before beginning any form of treatment, our OB-GYNs thoroughly discuss all treatment options with each patient.
Sex Therapy And Psychotherapy
Psychotherapy is frequently beneficial because it can aid in the resolution of unconscious conflicts from a woman's early development or current issues in her life. Some couples may require marriage/relationship counseling before or in addition to HSDD therapy. Sex therapy sessions, which may include dual sex therapy involving both partners, may be recommended.
Medications (Drug Therapy)
Flibanserin (marketed under the name Addyi) was approved by the FDA in 2015 for the treatment of generalized HSDD in premenopausal women. A nonhormonal daily medicine called flibanserin boosts sexual desire and the frequency of pleasant sexual encounters.
Off-Label Use Of Other Drugs Can Also Treat HSDD. These Are Some Examples:
- Testosterone is commonly prescribed to perimenopausal and postmenopausal women to help balance reproductive hormones, which influence sexual arousal, sex drive, and distress. Systemic hormone therapy is only advised for postmenopausal women.
- Bupropion an antidepressant that has been shown to improve sexual function, arousal, and orgasm in HSDD women. This is a daily medication that is especially beneficial in HSDD caused by SSRIs, which are antidepressants.
- Buspirone is an anxiety medication that can increase sexual interest. This can be taken before sexual activity and is especially beneficial in HSDD caused by SSRIs.
Patient monitoring is required for all treatment choices because the risks of these off-label medications for HSSD patients have not been fully analyzed.
While there is no cure for HSDD, there are treatments that can help to reduce its symptoms. One treatment option is hormone replacement therapy (HRT), which can help to balance hormones and improve sexual desire. At Harbor Compound pharmacy, our team of experts can help you explore your treatment options and find the best plan for your needs. We offer confidential consultations and individualized care, so you can get the help you need in a safe and comfortable environment. Contact us today to learn more about female sexual health and how we can help you manage HSDD.
About the Creator
Harbor Compounding pharmacy
Harbor Compounding Pharmacy in California to provide better health solutions. The aim of this health pharmacy is to provide solutions to all health-related issues. It provides treatment for all diseases and health counseling.
There are no comments for this story
Be the first to respond and start the conversation.